---
document_datetime: 2025-12-02 05:26:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/duloxetine-boehringer-ingelheim.html
document_name: duloxetine-boehringer-ingelheim.html
version: success
processing_time: 0.1020811
conversion_datetime: 2025-12-25 11:07:39.645072
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Duloxetine Boehringer Ingelheim

[RSS](/en/individual-human-medicine.xml/65513)

##### Withdrawn

This medicine's authorisation has been withdrawn

duloxetine Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On the 8th October 2008 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Duloxetine Boehringer Ingelheim, duloxetine, which had been approved for the treatment of diabetic peripheral neuropathic pain in adults. The marketing authorisation holder (MAH) responsible for Duloxetine Boehringer Ingelheim was Boehringer Ingelheim International GmbH.

The European Commission was notified by a letter dated 12 April 2010 of the MAH's decision to voluntarily withdraw the marketing authorisation as of the Commission Decision date for Duloxetine Boehringer Ingelheim for commercial reasons.

Duloxetine Boehringer Ingelheim was not marketed in any European country. On 26th May 2010 the European Commission issued a decision to withdraw the marketing authorisation for Duloxetine Boehringer Ingelheim.

Pursuant to this decision the European Public Assessment Report for Duloxetine Boehringer Ingelheim is updated to reflect that the marketing authorisation is no longer valid.

Duloxetine Boehringer Ingelheim : EPAR - Summary for the public

English (EN) (271.06 KB - PDF)

**First published:** 17/08/2009

**Last updated:** 17/08/2009

[View](/en/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-151)

български (BG) (452.19 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/bg/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_bg.pdf)

español (ES) (275.13 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/es/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_es.pdf)

čeština (CS) (421.81 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/cs/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_cs.pdf)

dansk (DA) (272.92 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/da/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_da.pdf)

Deutsch (DE) (275.83 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/de/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_de.pdf)

eesti keel (ET) (492.34 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/et/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_et.pdf)

ελληνικά (EL) (451.96 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/el/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_el.pdf)

français (FR) (274.9 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/fr/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_fr.pdf)

italiano (IT) (495.52 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/it/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_it.pdf)

latviešu valoda (LV) (427.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/lv/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (393.88 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/lt/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_lt.pdf)

magyar (HU) (409.78 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/hu/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_hu.pdf)

Malti (MT) (420.82 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/mt/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_mt.pdf)

Nederlands (NL) (273.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/nl/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_nl.pdf)

polski (PL) (431.59 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/pl/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_pl.pdf)

português (PT) (274.47 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/pt/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_pt.pdf)

română (RO) (387.33 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/ro/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_ro.pdf)

slovenčina (SK) (415.13 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sk/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_sk.pdf)

slovenščina (SL) (652.91 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sl/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_sl.pdf)

Suomi (FI) (273.51 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/fi/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_fi.pdf)

svenska (SV) (272.73 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sv/documents/overview/duloxetine-boehringer-ingelheim-epar-summary-public_sv.pdf)

## Product information

Duloxetine Boehringer Ingelheim : EPAR - Product Information

English (EN) (545.27 KB - PDF)

**First published:** 17/08/2009

**Last updated:** 28/01/2010

[View](/en/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-646)

български (BG) (967.25 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/bg/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_bg.pdf)

español (ES) (583.9 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/es/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_es.pdf)

čeština (CS) (541.09 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/cs/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_cs.pdf)

dansk (DA) (578.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/da/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_da.pdf)

Deutsch (DE) (588.98 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/de/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_de.pdf)

eesti keel (ET) (581.38 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/et/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_et.pdf)

ελληνικά (EL) (997.7 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/el/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_el.pdf)

français (FR) (609.98 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/fr/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_fr.pdf)

italiano (IT) (569.07 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/it/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_it.pdf)

latviešu valoda (LV) (837.09 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/lv/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_lv.pdf)

lietuvių kalba (LT) (771.49 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/lt/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_lt.pdf)

magyar (HU) (705.83 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/hu/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_hu.pdf)

Malti (MT) (780.04 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/mt/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_mt.pdf)

Nederlands (NL) (599.55 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/nl/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_nl.pdf)

polski (PL) (830.47 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/pl/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_pl.pdf)

português (PT) (599.22 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/pt/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_pt.pdf)

română (RO) (743.43 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/ro/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_ro.pdf)

slovenčina (SK) (570.7 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/sk/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_sk.pdf)

slovenščina (SL) (696.09 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/sl/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_sl.pdf)

Suomi (FI) (608.7 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/fi/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_fi.pdf)

svenska (SV) (560.49 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

28/01/2010

[View](/sv/documents/product-information/duloxetine-boehringer-ingelheim-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** P46/008 07/12/2009

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Duloxetine Boehringer Ingelheim : EPAR - All Authorised presentations

English (EN) (224.75 KB - PDF)

**First published:** 28/10/2008

**Last updated:** 28/01/2010

[View](/en/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-672)

български (BG) (322.9 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/bg/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_bg.pdf)

español (ES) (223.34 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/es/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_es.pdf)

čeština (CS) (273.91 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/cs/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (224.46 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/da/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (223.13 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/de/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (223.49 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/et/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (316.36 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/el/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_el.pdf)

français (FR) (223.13 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/fr/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (223.12 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/it/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (316.7 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/lv/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (292.53 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/lt/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (274.52 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/hu/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (315.61 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/mt/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (223.77 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/nl/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_nl.pdf)

polski (PL) (315.91 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/pl/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_pl.pdf)

português (PT) (223.33 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/pt/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_pt.pdf)

română (RO) (288.79 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/ro/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (273.54 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/sk/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (247.19 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/sl/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (223.23 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/fi/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (229.64 KB - PDF)

**First published:**

28/10/2008

**Last updated:**

28/01/2010

[View](/sv/documents/all-authorised-presentations/duloxetine-boehringer-ingelheim-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Duloxetine Boehringer Ingelheim Active substance duloxetine International non-proprietary name (INN) or common name duloxetine Therapeutic area (MeSH) Diabetic Neuropathies Anatomical therapeutic chemical (ATC) code N06AX21

### Pharmacotherapeutic group

Psychoanaleptics

### Therapeutic indication

Treatment of diabetic peripheral neuropathic pain in adults.

## Authorisation details

EMA product number EMEA/H/C/001007 Marketing authorisation holder

Boehringer Ingelheim International GmbH

Binger Str 173

Marketing authorisation issued 08/10/2008 Withdrawal of marketing authorisation 26/05/2010 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Duloxetine Boehringer Ingelheim : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (478.7 KB - PDF)

**First published:** 17/08/2009

**Last updated:** 28/01/2010

[View](/en/documents/procedural-steps-after/duloxetine-boehringer-ingelheim-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Duloxetine Boehringer Ingelheim-H-C-1007-A46-08 : EPAR - Assessment Report

Reference Number: EMA/18262/2013

English (EN) (993.99 KB - PDF)

**First published:** 17/01/2013

**Last updated:** 17/01/2013

[View](/en/documents/variation-report/duloxetine-boehringer-ingelheim-h-c-1007-a46-08-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Duloxetine Boehringer Ingelheim : EPAR - Public assessment report

English (EN) (513.09 KB - PDF)

**First published:** 28/10/2008

**Last updated:** 28/10/2008

[View](/en/documents/assessment-report/duloxetine-boehringer-ingelheim-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Duloxetine Boehringer Ingelheim

Reference Number: EMEA/CHMP/333730/2008

English (EN) (33.91 KB - PDF)

**First published:** 24/07/2008

**Last updated:** 24/07/2008

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-duloxetine-boehringer-ingelheim_en.pdf)

**This page was last updated on** 17/01/2013

## Share this page

[Back to top](#main-content)